TrialJournal of neuro-oncology2019

Efficacy of initial temozolomide for high-risk low grade gliomas in a phase II AINO (Italian Association for Neuro-Oncology) study: a post-hoc analysis within molecular subgroups of WHO 2016.

Roberta Rudà et al.PubMed ↗Publisher ↗

No numbers read from the abstract.